Cholinergic regulation on polymeric immunoglobulin receptor expression in Caco-2 cells
Acta Pharmaceutica · 01.09.2025 · 75 (3) · 547-555
DOI: 10.2478/acph-2025-0033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, online erschienen am 10.10.2025. Verfasst von German Higuera-Martínez und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz M…. Hauptthemen laut MEDLINE: Receptors, Polymeric Immunoglobulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The polymeric immunoglobulin receptor (pIgR) mediates trans cytosis of IgA, a pivotal anti-inflammatory player of the mucosal immune system. Transcytosis mediated by pIgR entails protein effectors of vesicle-mediated transport involved in signal pathway activation that lead to the sorting of pIgR-IgA complexes from the basolateral to apical membrane. Each step of pIgR transport encompasses multiple targets for regulation, but the role of cholinergic system components, i.e. acetylcholine (ACh), the ligand of nicotinic (nAChR) and muscarinic (mAChR) receptors, is unclear. This study evaluated the effect of the cholinergic system on pIgR at transcriptional and protein levels. Accordingly, lipopolysaccharide (LPS)-primed Caco-2 cells were treated with nicotine (nAChR agonist) and/or mecamylamine (nAChR antagonist) or with muscarine (mAChR agonist) and/ or atropine (mAChR antagonist), and then pIgR was analysed in situ by immunofluorescence and by RT-qPCR. In general terms, cholinergic antagonists counteracted the upmodu latory outcome of both cholinergic agonists on both pIgR cellular location and mRNA levels. These findings suggest that the cholinergic system plays a key role in the regulation of epithelial immunity by modulating pIgR expression. The study provides insights into the interaction between the cholinergic system and intestinal immune mechanisms for future research in mucosal immunity and possible therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz Mirón s/n, CP 11340 CDMX México.
- 2Departamento de Sistemas Biológicos Universidad Autónoma Metropolitana Unidad Xochimilco, Calzada del Hueso No. 1100 CP 04960 CDMX, México.
ORCID-Profile: German Higuera-Martínez, David Levaro-Loquio, Aldo Arturo Reséndiz-Albor, Ivonne Maciel Arciniega Martínez, Munich Guevara-Rubio, Maria Elisa Drago-Serrano, Judith Pacheco-Yepez
Zitieren
APA
Higuera-Martínez, G., Levaro-Loquio, D., Reséndiz-Albor, A. A., Martínez, I. M. A., Guevara-Rubio, M., Drago-Serrano, M. E., & Pacheco-Yepez, J. (2025). Cholinergic regulation on polymeric immunoglobulin receptor expression in Caco-2 cells. Acta Pharmaceutica, 75(3), 547-555. https://doi.org/10.2478/acph-2025-0033
Vancouver
Higuera-Martínez G, Levaro-Loquio D, Reséndiz-Albor AA, Martínez IMA, Guevara-Rubio M, Drago-Serrano ME, et al. Cholinergic regulation on polymeric immunoglobulin receptor expression in Caco-2 cells. Acta Pharmaceutica. 2025;75(3):547-555. doi:10.2478/acph-2025-0033
BibTeX
@article{HigueraMartnez2025,
author = {Higuera-Martínez, German and Levaro-Loquio, David and Reséndiz-Albor, Aldo Arturo and Martínez, Ivonne Maciel Arciniega and Guevara-Rubio, Munich and Drago-Serrano, Maria Elisa and Pacheco-Yepez, Judith},
title = {Cholinergic regulation on polymeric immunoglobulin receptor expression in Caco-2 cells},
journal = {Acta Pharmaceutica},
year = {2025},
volume = {75},
number = {3},
pages = {547--555},
doi = {10.2478/acph-2025-0033}
}
EUVIMED